Evidence map›Paper›PMID 28467203›Full record

ReviewDiabetes & vascular disease research2017

Gaps and barriers in the control of blood glucose in people with type 2 diabetes.

Lawrence Blonde, Pablo Aschner, Clifford Bailey, Linong Ji, Lawrence A Leiter, Stephan Matthaei, Global Partnership for Effective Diabetes Management

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diabetes & vascular disease research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 3 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 3 syntheses or guidelines pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Efficacy and safety ofBMJ open · 2025
    Article
  18. Article
  19. Systematic Literature Review of the Impact of Type 2 Diabetes and Heart Failure Guideline Adherence on Clinical and Economic Outcomes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Review
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 6 countries.

Lawrence Blonde1 Department of Endocrinology, Ochsner Medical Center, New Orleans, LA, USA.
Pablo Aschner2 Endocrinology Unit, Javeriana University School of Medicine, Bogotá, Colombia.
Clifford Bailey3 School of Life & Health Sciences, Aston University, Birmingham, UK.
Linong Ji4 Peking University People's Hospital, Beijing, China.
Lawrence A Leiter5 Keenan Research Center in the Li Ka Shing Knowledge Institute, St. Michael's Hospital and Division of Endocrinology & Metabolism, University of Toronto, Toronto, ON, Canada.
Stephan Matthaei6 Diabetes, Metabolism and Endocrinology Center, Quakenbrück Hospital, Quakenbrück, Germany.
Global Partnership for Effective Diabetes Management
Aston University · GBDiabetes-Zentrum Quakenbrück · DEOchsner Medical Center · USPeking University People's Hospital · CNPontificia Universidad Javeriana · COUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlycaemic control is suboptimal in a large proportion of people with type 2 diabetes who are consequently at an increased and avoidable risk of potentially severe complications. We sought to explore attitudes and practices among healthcare professionals that may contribute to suboptimal glycaemic control through a review of recent relevant publications in the scientific literature.

methodsAn electronic search of the PubMed database was performed to identify relevant publications from January 2011 to July 2015. The electronic search was complemented by a manual search of abstracts from key diabetes conferences in 2014/2015 available online.

resultsRecently published data indicate that glycaemic control is suboptimal in a substantial proportion (typically 40%-60%) of people with diabetes. This is the case across geographic regions and in both low- and higher-income countries. Therapeutic inertia appears to be an important contributor to poor glycaemic control in up to half of people with type 2 diabetes. In particular, prescribers are often willing to tolerate extended periods of 'mild' hyperglycaemia as well as having low expectations for their patients. There are often delays of 3 years or longer in initiating or intensifying glucose-lowering therapy when needed.

conclusionMany people with type 2 diabetes are failed by current management, with approximately half not achieving or maintaining appropriate target blood glucose levels, leaving these patients at increased and avoidable risk of serious complications. Review criteria: The methodology of this review article is detailed in the 'Methods' section.

Indexed as

BiomarkersBlood GlucoseDiabetes Mellitus, Type 2Drug SubstitutionDrug Therapy, CombinationGlycated HemoglobinGuideline AdherenceHumansHypoglycemic AgentsPractice Guidelines as TopicPractice Patterns, Physicians'Risk FactorsTime FactorsTime-to-TreatmentTreatment OutcomeBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic Agentsclinical inertiaDiabetes mellitusglycaemic controlreviewsurveystype 2

Identifiers

PMID28467203
PMCPMC5418936
OpenAlexW2591702989

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.